We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Hollis-Eden’s Neumune for Clinical Trials
FDA Approves Hollis-Eden’s Neumune for Clinical Trials
June 8, 2006
The FDA has given clearance for a Phase I/II clinical trial of Hollis-Eden’s investigational compound Neumune, which combats healthcare-associated (nosocomial) infections.